✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals
Market Cap
₹11 Cr.
P/E
26.63

Key Ratios

Market cap
Market cap
11.00 Cr
PE
PE
26.63
Prom Holding
Prom Holding
61.58 %
ROE (%)
ROE (%)
10.46
ROCE (%)
ROCE (%)
15.72
Div Yield (%)
Div Yield (%)
-
Sales
Sales
8.23 Cr
OPM (%)
OPM (%)
10.12 %
Debt to Equity
Debt to Equity
0.24

About

Clinitech Laboratory is a trusted provider of diagnostic and healthcare tests through a chain … Read more
Low
29
52W Range
High
99
  • Clinitech Laboratory
  • DhanvantriJeevan Rek
  • Broach Lifecare Hosp

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

4 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Clinitech Laboratory Ltd. Business

Clinitech Laboratory is one of the most trusted diagnostic centers & pathology labs. The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic centers. It conducts various tests at its centres which are classified under various heads as under: Biochemistry tests; Immunology tests; Hematology tests; Molecular Biology tests; Serology tests; Microbiology tests; and Histopathology tests.

Clinitech Laboratory major competitors are DhanvantriJeevan Rek, Broach Lifecare Hosp, Dr Lalchandani Labs, Looks Health Service, Gian Life Care, Dolphin Medical Serv, Nidan Labs. & Health.
Market Cap of Clinitech Laboratory is ₹11 Crs.
While the median market cap of its peers are ₹12 Crs.

Clinitech Laboratory seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material